Clinical Supply Logistic Articles

1. Building Stronger Sponsor–Vendor Relationships 8/12/2026

   Strong sponsor-vendor partnerships are built on trust, transparency, and shared goals. Learn how better communication helps teams reduce risk and keep trials on track.

2. When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line 8/11/2026

   Clinical supply plans can look perfect on paper but fail at the site. A Moorfields surgeon explains how supply delays, packaging, and workflow gaps affect trials and patients.

3. Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next 8/10/2026

   Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.

4. Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges 8/10/2026

   Customs delays can derail clinical trials in days. Learn practical strategies for import compliance, digital preclearance, and resilient cross-border logistics.

5. Fast, Secure, And Defensible: Building Decisions That Can Be Challenged Internally And Defended Externally 8/7/2026

   When clinical supply decisions face uncertainty, speed alone is not enough. Learn how governance frameworks create faster, more secure, and defensible actions.

6. Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics 8/6/2026

   Cold chain failures can destroy biologics and cell therapies. Learn how real-time monitoring, validated packaging, and lane qualification reduce risk and protect patients.

7. The Overlap Nobody Talks About: Packaging Decisions And Stability Budgets 8/4/2026

   Packaging decisions shape far more than product protection. Discover how stability budgets and temperature excursion planning can prevent waste and reduce trial risk.

8. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

   Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.

9. How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies 7/31/2026

   From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.

10. Reshoring Pressure Meets Manufacturing Reality 7/27/2026

    U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.